BNET Industries

Sangamo BioSciences Inc.

(SGMO) is in the Pharma Industry

Market Cap:$233.0M
Last Fiscal Year Sales:$16.1M
  • Public
  • US
Dow Jones Description

We are developing ZFP TFs for direct use in the patient to either turn on therapeutically beneficial genes or turn off the expression of disease-causing .

Number of Employees 77
Contact Information

Point Richmond Tech Ctr II 501 Canal Blvd Ste A100

Richmond, California 94804

sangamo.com

(510) 970-6000

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Sangamo SGMO Reports Q3 Loss of $0.12, Beats by 1c

    11/04/09 - Financial Announcement - View Story

  • BUYINS.NET: BTI, BPFH, TYL, EEFT, OSTK, SGMO Expected To Be Higher After Earnings Releases on...

    10/27/09 - Joint Venture / Alliance - View Story

  • Sigma-Aldrich profit up, sales drop slightly

    10/22/09 - New Investment - View Story

  • Sangamo BioSciences raises $21.6 million in public offering

    10/14/09 - New Investment - View Story

  • Sangamo BioSciences, Inc. SGMO Lands $20 Million in Expanded Sigma-Aldrich Corporation SIAL Deal

    10/05/09 - New Investment - View Story

  • Sigma-AldrichR and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement Sigma-Aldrich to Exclusively...

    10/05/09 - Joint Venture / Alliance - View Story

  • Sangamo BioSciences Reports Second Quarter 2009 Financial Results

    7/29/09 - Financial Announcement - View Story

  • Sangamo BioSciences, Inc. SGMO Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech,...

    6/29/09 - Joint Venture / Alliance - View Story

News & Analysis

call transcript and sangamo biosciences inc. - All News and Analysis

advertisement
     SGMO $5.27 -0.06 (-1.13% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 366,854
Shares Outstanding 44.91M
Market Cap 236.7M
Year High 9.39
Year Low 2
Earnings Per Share -0.47
P/E Ratio -11.21
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement